La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Wellell Bilan de santé

Santé financière contrôle des critères 6/6

Wellell possède un total de capitaux propres de NT$2.4B et une dette totale de NT$262.2M, ce qui porte son ratio d'endettement à 11.1%. Son actif total et son passif total sont NT$3.2B et de NT$807.0M. L'EBIT de Wellell est NT$149.0M ce qui fait que son ratio de couverture des intérêts 19.2. Elle dispose de liquidités et de placements à court terme de NT$724.8M.

Informations clés

11.1%

Ratio d'endettement

NT$262.22m

Dette

Ratio de couverture des intérêts	19.2x
Argent liquide	NT$724.84m
Fonds propres	NT$2.37b
Total du passif	NT$806.98m
Total des actifs	NT$3.18b

Mises à jour récentes de la santé financière

Is Apex Medical (TPE:4106) Using Too Much Debt?

Jan 12

Recent updates

Should You Or Shouldn't You: A Dividend Analysis on Apex Medical Corp. (TPE:4106)

Mar 29

Reflecting on Apex Medical's (TPE:4106) Share Price Returns Over The Last Five Years

Mar 01

Returns On Capital At Apex Medical (TPE:4106) Paint An Interesting Picture

Feb 11

Weak Financial Prospects Seem To Be Dragging Down Apex Medical Corp. (TPE:4106) Stock

Jan 27

Is Apex Medical (TPE:4106) Using Too Much Debt?

Jan 12

Is Apex Medical Corp. (TPE:4106) A Good Fit For Your Dividend Portfolio?

Dec 28

Does Apex Medical's (TPE:4106) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 13

Apex Medical (TPE:4106) Share Prices Have Dropped 28% In The Last Five Years

Nov 27

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 4106 ( NT$1.7B ) dépassent ses passifs à court terme ( NT$658.6M ).

Passif à long terme: Les actifs à court terme de 4106 ( NT$1.7B ) dépassent ses passifs à long terme ( NT$148.3M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: 4106 dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de 4106 a été réduit de 34.2% à 11.1% au cours des 5 dernières années.

Couverture de la dette: La dette de 4106 est bien couverte par le flux de trésorerie opérationnel ( 131% ).

Couverture des intérêts: Les paiements d'intérêts de 4106 sur sa dette sont bien couverts par l'EBIT ( 19.2 x couverture).

Wellell Bilan de santé

Santé financière contrôle des critères 6/6

Informations clés

Mises à jour récentes de la santé financière

Is Apex Medical (TPE:4106) Using Too Much Debt?

Recent updates

New minor risk - Profit margin trend

Second quarter 2024 earnings released: EPS: NT$0.21 (vs NT$0.50 in 2Q 2023)

Wellell Inc. to Report Q2, 2024 Results on Aug 13, 2024

Upcoming dividend of NT$0.80 per share

Wellell's (TWSE:4106) Dividend Is Being Reduced To NT$0.80

Wellell (TWSE:4106) Has Announced That Its Dividend Will Be Reduced To NT$0.80

Dividend reduced to NT$0.80

Wellell Inc. Approves Common Stock Cash Dividend, Payable on August 26, 2024

First quarter 2024 earnings released: EPS: NT$0.40 (vs NT$0.50 in 1Q 2023)

Wellell Inc. to Report Q1, 2024 Results on May 08, 2024

Wellell Inc. to Report Q1, 2024 Results on May 08, 2024

Some May Be Optimistic About Wellell's (TWSE:4106) Earnings

Wellell Inc. Appoints Su Ya-Ling as Chief Operating Officer

Full year 2023 earnings released: EPS: NT$1.51 (vs NT$1.60 in FY 2022)

Wellell Inc., Annual General Meeting, Jun 24, 2024

Wellell Inc. Appoints Lee Pi Kai as Chief Strategy Officer

Wellell Inc. Announces Resignation of Tan, Jian-Qiang as Chief Operating Officer

Second quarter 2023 earnings released: EPS: NT$0.50 (vs NT$0.51 in 2Q 2022)

Upcoming dividend of NT$0.85 per share at 2.7% yield

New minor risk - Dividend sustainability

Investor sentiment improves as stock rises 16%

Wellell Inc. Appoints Shin-Ho,Chen as Corporate Governance Officer

Full year 2022 earnings released: EPS: NT$1.60 (vs NT$1.01 in FY 2021)

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: NT$0.59 (vs NT$0.31 in 3Q 2021)

Insufficient new directors

Wellell Inc. Announces Change Member of Remuneration Committee

Second quarter 2022 earnings released: EPS: NT$0.51 (vs NT$0.34 in 2Q 2021)

Insufficient new directors

Apex Medical Corp. Approves Cash Dividend for the Year 2021

Apex Medical Corp. Announces Change of Alan Chang as Research and Development Officer, Effective May 31, 2022

Apex (Kunshan)Medical Corp. to Announce Production Can Be Resume Gradually

Apex Medical Corp. Announces On Behalf of the Subsidiaries Apex (Kunshan) Medical Corp. and Wellell (Kunshan) Co., Ltd. Extend Temporary Suspension of Production

Wellell (Kunshan) Co., Ltd. Announces the Temporary Suspension of Production

Full year 2021 earnings released: EPS: NT$1.01 (vs NT$1.04 in FY 2020)

Wellell Inc., Annual General Meeting, Jun 20, 2022

Third quarter 2021 earnings released: EPS NT$0.31 (vs NT$0.28 in 3Q 2020)

High number of new directors

High number of new directors

High number of new directors

Upcoming dividend of NT$0.55 per share

Second quarter 2021 earnings released: EPS NT$0.34 (vs NT$0.55 in 2Q 2020)

High number of new directors

High number of new directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS NT$0.29 (vs NT$0.074 in 1Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$1.04 (vs NT$0.87 in FY 2019)

Should You Or Shouldn't You: A Dividend Analysis on Apex Medical Corp. (TPE:4106)

Reflecting on Apex Medical's (TPE:4106) Share Price Returns Over The Last Five Years

Apex Medical Corp. Announces Executive Changes, Effective March 01, 2021

Returns On Capital At Apex Medical (TPE:4106) Paint An Interesting Picture

Apex Medical Corp. Appoints Alan Chang as Director of R&D

New 90-day low: NT$25.65

Weak Financial Prospects Seem To Be Dragging Down Apex Medical Corp. (TPE:4106) Stock

Is Apex Medical (TPE:4106) Using Too Much Debt?

New 90-day low: NT$28.00

Is Apex Medical Corp. (TPE:4106) A Good Fit For Your Dividend Portfolio?

Does Apex Medical's (TPE:4106) Statutory Profit Adequately Reflect Its Underlying Profit?

New 90-day low: NT$28.90

Apex Medical (TPE:4106) Share Prices Have Dropped 28% In The Last Five Years

Third quarter 2020 earnings released: EPS NT$0.28

New 90-day low: NT$31.05

First half earnings released

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines